Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts.

Source:http://linkedlifedata.com/resource/pubmed/id/11502962

Transplantation 2001 Aug 15 72 3 364-8

Download in:

View as

Triples

General Info

PMID
11502962